Literature DB >> 30980360

Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.

Guangshun Wang1, Jayaram Lakshmaiah Narayana2, Biswajit Mishra2, Yingxia Zhang2, Fangyu Wang2, Chunfeng Wang2, D Zarena2, Tamara Lushnikova2, Xiuqing Wang2.   

Abstract

The incorporation of the innate immune system into humans is essential for survival and health due to the rapid replication of invading microbes and the delayed action of the adaptive immune system. Antimicrobial peptides are important components of human innate immunity. Over 100 such peptides have been identified in various human tissues. Human cathelicidin LL-37 is best studied, and there has been a growing interest in designing new peptides based on LL-37. This chapter describes the alternative processing of the human cathelicidin precursor, protease digestion, and lab cutting of LL-37. Both a synthetic peptide library and structure-based design are utilized to identify the active regions. Although challenging, the determination of the 3D structure of LL-37 enabled the identification of the core antimicrobial region. The minimal region of LL-37 can be function-dependent. We discuss the design and potential applications of LL-37 into antibacterial, antibiofilm, antiviral, antifungal, immune modulating, and anticancer peptides. LL-37 has been engineered into 17BIPHE2, a stable, selective, and potent antimicrobial, antibiofilm, and anticancer peptide. Both 17BIPHE2 and SAAP-148 can eliminate the ESKAPE pathogens and show topical in vivo antibiofilm efficacy. Also discussed are other application strategies, including peptide formulation, antimicrobial implants, and peptide-inducing factors such as vitamin D and sunlight. Finally, we summarize what we learned from peptide design based on human LL-37.

Entities:  

Keywords:  Anticancer peptides; Antimicrobial peptides; Antiviral peptides; Cathelicidins; LL-37; Peptide design

Mesh:

Substances:

Year:  2019        PMID: 30980360     DOI: 10.1007/978-981-13-3588-4_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  39 in total

1.  The antimicrobial peptide database provides a platform for decoding the design principles of naturally occurring antimicrobial peptides.

Authors:  Guangshun Wang
Journal:  Protein Sci       Date:  2019-08-10       Impact factor: 6.725

2.  Resistome of Staphylococcus aureus in Response to Human Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides.

Authors:  Radha M Golla; Biswajit Mishra; Xiangli Dang; Jayaram Lakshmaiah Narayana; Amy Li; Libin Xu; Guangshun Wang
Journal:  ACS Infect Dis       Date:  2020-05-11       Impact factor: 5.084

3.  Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.

Authors:  Jayaram Lakshmaiah Narayana; Biswajit Mishra; Tamara Lushnikova; Radha M Golla; Guangshun Wang
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-07-15       Impact factor: 3.747

4.  Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism.

Authors:  Qianhui Wu; Biswajit Mishra; Guangshun Wang
Journal:  Pept Sci (Hoboken)       Date:  2022-04-25

5.  Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.

Authors:  Martin van Eijk; Stephanie Boerefijn; Lida Cen; Marisela Rosa; Marnix J H Morren; Cornelis K van der Ent; Bart Kraak; Jan Dijksterhuis; Ivan D Valdes; Henk P Haagsman; Hans de Cock
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

6.  Protection or Destruction: The LL-37/HNP1 Cooperativity Switch.

Authors:  Tyler S Johnson; Charles M Deber
Journal:  Biophys J       Date:  2020-11-25       Impact factor: 4.033

Review 7.  The evolution of the antimicrobial peptide database over 18 years: Milestones and new features.

Authors:  Guangshun Wang; C Michael Zietz; Ashok Mudgapalli; Shuona Wang; Zhe Wang
Journal:  Protein Sci       Date:  2021-09-24       Impact factor: 6.725

8.  Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37.

Authors:  Jayaram Lakshmaiah Narayana; Radha Golla; Biswajit Mishra; Xiuqing Wang; Tamara Lushnikova; Yingxia Zhang; Atul Verma; Vikas Kumar; Jingwei Xie; Guangshun Wang
Journal:  ACS Infect Dis       Date:  2021-04-23       Impact factor: 5.578

Review 9.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29

Review 10.  The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.

Authors:  Bee Ha Gan; Josephine Gaynord; Sam M Rowe; Tomas Deingruber; David R Spring
Journal:  Chem Soc Rev       Date:  2021-07-05       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.